Retatrutide, developed by Soma, represents a significant development in weight regulation. This unique drug combines GLP-1 receptor agonist function with gut-derived receptor agonist stimulation , demonstrating impressive results in clinical data for body loss . Researchers believe this treatment may offer a alternative solution for people facing w